# Martin Ekwealor Pharmaceuticals, Inc. – FDA Inspection, Feb 17, 2010

Source: https://www.keypedia.com/records/fda_inspections/martin-ekwealor-pharmaceuticals-inc/a660f0a3-01dd-421d-89d3-39014f6d005c
Source feed: FDA_Inspections

> FDA inspection 648367 of Martin Ekwealor Pharmaceuticals, Inc., February 17, 2010. Classification: Voluntary Action Indicated (VAI). 1 citation under 21 CFR part 211. 3 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 648367
- Company Name: Martin Ekwealor Pharmaceuticals, Inc.
- Inspection Date: 2010-02-17
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 1

## Related Documents

- FDA Inspection 1037070 - 2017-12-13
- FDA Inspection 963197 - 2016-03-24
- [FDA Inspection 741026 - 2011-07-29](https://www.keypedia.com/records/fda_inspections/martin-ekwealor-pharmaceuticals-inc/55bc5963-f909-4fad-81fb-50530d7015ef)

Company: https://www.keypedia.com/companies/martin-ekwealor-pharmaceuticals-inc/df2d727e-9b86-4711-b3e7-0b381ab35fe9

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c